Device Trial Radar · NCT04032470
Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)
Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Oct 23, 2019
Primary completion
Dec 2039
Study completion Dec 2039
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- Jul 25, 2019
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
To compile characteristics of real-world outcomes for Boston Scientific Corporation's commercially approved Deep Brain Stimulation (DBS) Systems, when used according to the applicable Directions for Use, for the treatment of Essential Tremor.
Conditions
- Essential Tremor
Interventions
Deep Brain Stimulation Systems (DBS)Device
Subjects receiving DBS implant for treatment of Essential Tremor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Quality of Life during the study as compared with baseline using the Quality of Life in Essential Tremor Questionnaire (QUEST)Time frame: Up to 3 years
Locations
20 sites in 9 countries. Site status is shown where the registry gives one.
A.o. LKH Univ.-Kliniken Innsbruck
Innsbruck, Austria · Recruiting
AZ Sint-Lucas
Ghent, Belgium · Recruiting
UZ Gasthuisberg
Leuven, Belgium · Recruiting
17 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.